KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Other Non-Current Assets (2020 - 2025)

Hims & Hers Health's Other Non-Current Assets history spans 6 years, with the latest figure at $1.9 million for Q2 2025.

  • For Q2 2025, Other Non-Current Assets rose 118.22% year-over-year to $1.9 million; the TTM value through Jun 2025 reached $1.9 million, up 118.22%, while the annual FY2024 figure was $147000.0, 82.83% down from the prior year.
  • Other Non-Current Assets for Q2 2025 was $1.9 million at Hims & Hers Health, down from $1.9 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.9 million in Q1 2025 and bottomed at $147000.0 in Q4 2024.
  • The 5-year median for Other Non-Current Assets is $856000.0 (2021), against an average of $933166.7.
  • The largest annual shift saw Other Non-Current Assets crashed 82.83% in 2024 before it skyrocketed 126.87% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $856000.0 in 2021, then changed by 0.0% to $856000.0 in 2022, then changed by 0.0% to $856000.0 in 2023, then plummeted by 82.83% to $147000.0 in 2024, then soared by 1170.75% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Other Non-Current Assets are $1.9 million (Q2 2025), $1.9 million (Q1 2025), and $147000.0 (Q4 2024).